Successful treatment of relapsed FLT3-mutated donor cell-derived MDS/AML with FLT3 inhibitor gilteritinib.
Saved in:
| Title: | Successful treatment of relapsed FLT3-mutated donor cell-derived MDS/AML with FLT3 inhibitor gilteritinib. |
|---|---|
| Authors: | Kawano M; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan., Kunimoto H; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan. kunimoto@yokohama-cu.ac.jp., Izumi A; Department of Hematology and Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan., Adachi A; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan., Miura A; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan., Yokoyama C; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan., Hasegawa K; Department of Hematology and Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan., Shirafuta M; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan., Tanaka M; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan., Sakuma T; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan., Ohashi T; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan., Takahashi H; Department of Hematology and Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan., Miyazaki T; Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan., Tachibana T; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan., Hagihara M; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan., Matsumoto K; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan., Nakajima H; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan. |
| Source: | Annals of hematology [Ann Hematol] 2026 Feb 23; Vol. 105 (4). Date of Electronic Publication: 2026 Feb 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41729290 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Successful treatment of relapsed FLT3-mutated donor cell-derived MDS/AML with FLT3 inhibitor gilteritinib. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kawano+M%22">Kawano M</searchLink>; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.<br /><searchLink fieldCode="AU" term="%22Kunimoto+H%22">Kunimoto H</searchLink>; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan. kunimoto@yokohama-cu.ac.jp.<br /><searchLink fieldCode="AU" term="%22Izumi+A%22">Izumi A</searchLink>; Department of Hematology and Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Adachi+A%22">Adachi A</searchLink>; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.<br /><searchLink fieldCode="AU" term="%22Miura+A%22">Miura A</searchLink>; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.<br /><searchLink fieldCode="AU" term="%22Yokoyama+C%22">Yokoyama C</searchLink>; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.<br /><searchLink fieldCode="AU" term="%22Hasegawa+K%22">Hasegawa K</searchLink>; Department of Hematology and Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Shirafuta+M%22">Shirafuta M</searchLink>; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.<br /><searchLink fieldCode="AU" term="%22Tanaka+M%22">Tanaka M</searchLink>; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.<br /><searchLink fieldCode="AU" term="%22Sakuma+T%22">Sakuma T</searchLink>; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.<br /><searchLink fieldCode="AU" term="%22Ohashi+T%22">Ohashi T</searchLink>; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.<br /><searchLink fieldCode="AU" term="%22Takahashi+H%22">Takahashi H</searchLink>; Department of Hematology and Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Miyazaki+T%22">Miyazaki T</searchLink>; Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Tachibana+T%22">Tachibana T</searchLink>; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.<br /><searchLink fieldCode="AU" term="%22Hagihara+M%22">Hagihara M</searchLink>; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.<br /><searchLink fieldCode="AU" term="%22Matsumoto+K%22">Matsumoto K</searchLink>; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.<br /><searchLink fieldCode="AU" term="%22Nakajima+H%22">Nakajima H</searchLink>; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229107334%22">Annals of hematology</searchLink> [Ann Hematol] 2026 Feb 23; Vol. 105 (4). <i>Date of Electronic Publication: </i>2026 Feb 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>9107334 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0584 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209395555%22">09395555 </searchLink><i>NLM ISO Abbreviation: </i>Ann Hematol <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41729290 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00277-026-06896-3 Languages: – Code: eng Text: English Titles: – TitleFull: Successful treatment of relapsed FLT3-mutated donor cell-derived MDS/AML with FLT3 inhibitor gilteritinib. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kawano M – PersonEntity: Name: NameFull: Kunimoto H – PersonEntity: Name: NameFull: Izumi A – PersonEntity: Name: NameFull: Adachi A – PersonEntity: Name: NameFull: Miura A – PersonEntity: Name: NameFull: Yokoyama C – PersonEntity: Name: NameFull: Hasegawa K – PersonEntity: Name: NameFull: Shirafuta M – PersonEntity: Name: NameFull: Tanaka M – PersonEntity: Name: NameFull: Sakuma T – PersonEntity: Name: NameFull: Ohashi T – PersonEntity: Name: NameFull: Takahashi H – PersonEntity: Name: NameFull: Miyazaki T – PersonEntity: Name: NameFull: Tachibana T – PersonEntity: Name: NameFull: Hagihara M – PersonEntity: Name: NameFull: Matsumoto K – PersonEntity: Name: NameFull: Nakajima H IsPartOfRelationships: – BibEntity: Dates: – D: 23 M: 02 Text: 2026 Feb 23 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1432-0584 Numbering: – Type: volume Value: 105 – Type: issue Value: 4 Titles: – TitleFull: Annals of hematology Type: main |
| ResultId | 1 |